As of 2026-03-14, the EV/EBITDA ratio of Abbott Laboratories (ABT) is 13.87. EV/EBITDA ratio is calculated by dividing the enterprise value by the TTM EBITDA. Abbott's latest enterprise value is 192,257.12 mil USD. Abbott's TTM EBITDA according to its financial statements is 13,861.00 mil USD. Dividing these 2 quantities gives us the above Abbott EV/EBITDA ratio.
| Range | Selected | |
| Trailing P/E multiples | 12.7x - 14.9x | 13.8x |
| Forward P/E multiples | 19.4x - 22.1x | 21.8x |
| Fair Price | 98.54 - 152.07 | 128.52 |
| Upside | -8.8% - 40.8% | 19.0% |
| Date | EV/EBITDA |
| 2026-03-13 | 13.87 |
| 2026-03-12 | 13.88 |
| 2026-03-11 | 14.15 |
| 2026-03-10 | 14.19 |
| 2026-03-09 | 14.45 |
| 2026-03-06 | 14.06 |
| 2026-03-05 | 14.25 |
| 2026-03-04 | 14.51 |
| 2026-03-03 | 14.57 |
| 2026-03-02 | 14.63 |
| 2026-02-27 | 14.91 |
| 2026-02-26 | 14.90 |
| 2026-02-25 | 14.71 |
| 2026-02-24 | 14.69 |
| 2026-02-23 | 14.78 |
| 2026-02-20 | 14.39 |
| 2026-02-19 | 14.39 |
| 2026-02-18 | 14.53 |
| 2026-02-17 | 14.40 |
| 2026-02-13 | 14.45 |
| 2026-02-12 | 14.30 |
| 2026-02-11 | 14.57 |
| 2026-02-10 | 14.40 |
| 2026-02-09 | 14.25 |
| 2026-02-06 | 14.22 |
| 2026-02-05 | 14.00 |
| 2026-02-04 | 13.89 |
| 2026-02-03 | 13.99 |
| 2026-02-02 | 14.04 |
| 2026-01-30 | 14.03 |
| 2026-01-29 | 13.63 |
| 2026-01-28 | 13.62 |
| 2026-01-27 | 13.90 |
| 2026-01-26 | 13.96 |
| 2026-01-23 | 13.79 |
| 2026-01-22 | 13.94 |
| 2026-01-21 | 15.46 |
| 2026-01-20 | 15.52 |
| 2026-01-16 | 15.59 |
| 2026-01-15 | 15.81 |
| 2026-01-14 | 16.00 |
| 2026-01-13 | 15.91 |
| 2026-01-12 | 15.95 |
| 2026-01-09 | 16.11 |
| 2026-01-08 | 16.15 |
| 2026-01-07 | 16.26 |
| 2026-01-06 | 16.35 |
| 2026-01-05 | 16.18 |
| 2026-01-02 | 15.90 |
| 2025-12-31 | 16.04 |